Changes in mean arterial pressure (MAP) and plasma catecholamine concentrations in response to endotracheal intubation were examined in 8 patients who had received d-tubocurarine and 10 who had received suxamethonium. MAP fell after induction of anaesthesia and administration of the relaxant by a mean of 11 mmHg in those who had received suxamethonium and 19 mmHg in those who had received d-tubocurarine (p <0.05 for each). MAP rose sharply when the trachea was intubated, by a mean of 29 mmHg for the suxamethonium group, and 35 mmHg for the curare group (p <0.001 for each). A significant rise in plasma noradrenaline was also noted after intubation in each group, 51 % (p <0.01) for the suxamethonium group and 28% (p <0.05) for the d-tubocurarine. The results suggest that thefall in MAP after administration of d-tubocurarine does not attenuate the pressor response associated with intubation.
investigators,3.4 and Fell et al. 4 demonstrated an increase in plasma noradrenaline after either suxamethonium or pancuronium was used to facilitate tracheal intubation. In view of the foregoing, a randomised trial was mounted to examine the effects of suxamethonium and d-tubocurarine on MAP and plasma catecholamine concentrations and to study the responses to subsequent endotracheal intubation.
METHODS Eighteen patients, aged from 20 to 78 years (mean 56 years), undergoing elective surgery were studied. They randomly received either suxamethonium 1.5 mg/kg (10 patients) or d-tubocurarine 0.4 mg/kg (8 patients) as the muscle relaxant to facilitate intubation of the trachea. Anaesthesia was induced with 
Mean plasma catecholamine concentrations (pmollml) and mean arterial pressures (mmHg) for the suxamethonium (S) and d-lUbocurarine (D) treated groups throughout induction and tracheal intubation. Mean values and standard deviations
shown. thiopentone and maintained with nitrous oxide/oxygen. No volatile anaesthetic agent was used until after the sampling sequence was complete.
On the night before operation the procedure of arterial cannulation and the sampling protocol was explained and consent obtained from the patient. An Allen's test to assess patency of the collateral circulation in the hand was performed in each case. Premedication was not standardised and was left to the individual preference of the duty anaesthetist; this was either a benzodiazepine or parenteral narcotic.
Prior to surgery, a 20 G Venflon cannula was inserted into the radial artery under local anaesthesia. A continuous trace of arterial blood pressure was obtained and sampling of arterial blood was performed through the cannula via a 3-way tap in the line. Samples (5 ml) were obtained immediately before induction, after administration of thiopentone and the relaxant, immediately before the trachea was intubated, and at 1 and 5 minutes after intubation. The mean time between the taking of the post-induction sample and the pre-intubation sample was 45 seconds in the patients given suxamethonium and 3 minutes in the patients given d-tubocurarine. Sampling was completed before the commencement of surgery.
Samples were stored on ice in heparinised tubes (lithium heparin 125/ . .1/10 ml) containing glutathione (5 mmolllitre) to prevent oxidation of the catecholamines. The tubes were transported on ice and centrifuged on completion of sampling. The decanted plasma was frozen and stored at -20 QC until the assay was performed, always within two weeks. The assay used was a modification of the radioenzymatic technique described by Oa Prada and Zurcher in 1976. 5 This is a reproducible assay with a coefficient of variation of less than 10070 and a recovery rating of 60-62070.
Results were analysed using the Student's t test (paired or unpaired) for means, or Fisher's exact test where groups were involved.
RESULTS
The two groups were similar with respect to sex distribution, body weight and age. Approximately equal numbers in each group received oral benzodiazepines and parenteral narcotics for premedication.
The data for MAP and plasma catecholamine concentrations are shown in Table 1 . The MAP before anaesthesia was 95 mmHg in each group and fell to a mean of 84 mmHg (SO 17) in the suxamethonium group and 76 mmHg (SO 20) in the d-tubocurarine group. For both of these falls p <0.05. One minute after intubation the MAP in the suxamethonium group was 115 mmHg (SO 22) and 103 mmHg (SO 21) in the d-tubocurarine group. Both these values were significantly (p <0.001) greater than the pre-intubation values.
No significant difference was demonstrated between the two groups in the mean plasma adrenaline noradrenaline and dopamine concentrations before the induction. These were within the ranges previously reported.1.4 After induction the mean plasma adrenaline concentration in the group given suxamethonium dropped from 0.37 to 0.19 pmollml (p <0.01) and the mean plasma noradrenaline concentration in the curare group dropped from 1.34 to 1.12 pmollml (p <0.05).
After intubation the mean plasma noradrenaline concentration rose from 1.29 (SD 0.51) to 1.95 pmollml (SD 0.78) in the suxamethonium group (p <0.01) and from 1.22 (SD 0.62) to 1.56 pmollml (SD 0.85) in the curare group (p <0.05). No other significant changes in catecholamine concentrations were demonstrated.
DISCUSSION
Stimulation of the upper respiratory tract results in an increase in MAP and heart rate which may not be tolerated well by some patients. Numerous methods have previously been employed to minimise these responses to endotracheal intubation. The application of topical lignocaine to the upper airway is time consuming and may in itself cause coughing and an increase in MAP. Intravenous lignocaine is probably the preferred method of administration in such circumstances. 6 The role of beta-adrenergic blocking drugs in preventing the pressure rise at intubation is controversial. Intravenous fentanyl7 and intravenous hydrallazine 8 have also been proposed as methods of attenuating these undesirable effects. There is no one method which guarantees haemodynamic stability.
It has been previously reported by a number of investigators that the use of pancuronium as a muscle relaxant results in a sharp rise in MAP and plasma noradrenaline and adrenaline on tracheal intubation. 1.3.4 Fell et al. 4 demonstrated a similar rise in plasma adrenaline and noradrenaline concentrations in response to intubation in patients who had received either suxamethonium or pancuronium. We were therefore interested to compare the changes associated with intubation in patients who had received suxamethonium and d-tubocurarine. The haemodynamic changes associated with the administ~.ation of the different muscle relaxants are well recognised. 9 Based on previous findings, it was predicted that MAP would fall significantly after administration of curare. The MAP fell less dramatically when suxamethonium was given. However, it was surprising that with both drugs the MAP rose on intubation so that at one minute there was no significant difference in the MAP between the two groups. This suggests that the fall in MAP which occurs on administering d-tubocurarine does not confer any advantage in attenuating the pressor response associated with intubation and that the mechanism of the hypotension induced by d-tubocurarine is histamine release and not ganglion blockade. If the mechanism were ganglion blockade, then intubation would not cause the sharp rise in MAP that was observed.
The plasma level of adrenaline fell after administration of thiopentone and the relaxant in both groups. These falls are difficult to interpret and may be related to induction of anaesthesia and not to the administration of the drugs themselves.
There was no significant rise in plasma dopamine or adrenaline with intubation in either group. However, the plasma noradrenaline rose by a mean of 51070 in the suxamethonium group and by 28% in the d-tubocurarine group on intubation. The rises in plasma noradrenaline paralleled the rises in MAP. The changes in plasma noradrenaline after suxamethonium resemble the values quoted by Fell et al. 4 in a group of 14 patients who had received either suxamethonium or pancuroni urn.
Despite considerable falls in MAP with the administration of d-tubocurarine, there was no benefit demonstrated in attenuating either the pressor or amine response to intubation. Thus, there appears to be no real advantage in choosing either suxamethoni urn or d-tubocurarine if attenuation of the pressor response to intubation is required.
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